Perseus Mining Half Year Results Perth, Feb. 24, 2025 (GLOBE NEWSWIRE) -- PERSEUS MINING’S HALF YEAR PROFIT UP 22% TO US$201M, NET CASH & BULLION UP US$117M TO US$704M Perth, Western Australia/ February 24, 2025/Mid-tier, gold producer, developer and explorer, Perseus Mining Limited (ASX/TSX:PRU) is pleased to report material improvements across all key financial metrics including revenue, EBITDA, profit after tax, operating cash flow and net cash position in its Interim Financial Report for the six months ending December 31, 2024 (H1 FY25). HIGHLIGHTS Revenue increased to US$581.8 mil...
Proposed Combination of Saipem and Subsea7 Milan, Luxembourg, 23 February 2025 - Saipem and Subsea7 announce that today they have reached an agreement in principle on the key terms of a possible merger of the two companies1 (the “Proposed Combination”) through the execution of a memorandum of understanding (the “MoU”). The Proposed Combination is expected to create a global leader in energy services. Highlights The combination of Saipem and Subsea7 (the “Combined Company”) will be renamed Saipem7, and will have a combined backlog of €43 billion2, Revenue of approx. €20 billion3 and EBITD...
The conservative CDU wins the elections as Germany's political landscape becomes more fragmented than ever
Estimates down on drydocks and softer rates; ABGSCe 51% above cons. on '26e EBITDA; TP of NOK 158 (167) – P/NAV 0.71x.
The centre -right CDU/CDU was the relative winner of this Sunday’s election coming in, based on the number available so far, slightly below 30%. The next government will be consequently led by Friedrich Merz. Depending on what the final result will be , different coalitions may be formed . Assuming that only five parties make it into the Bundestag – which seems currently the most likely outcome – a coalition between the CDU/CSU and the centre -left SPD would command a sufficient number...
IO Biotech Announces New Preclinical Data for Additional Pipeline Candidate Presented at the AACR-IO Conference • Findings support the development of a novel peptide vaccine targeting the immunosuppressive effects of Transforming Growth Beta (TGF-β) in solid tumors NEW YORK, Feb. 23, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today announced details of its poster presentation at the American Association for Cancer Research (AACR)-IO conference taking place F...
MUMBAI, India--(BUSINESS WIRE)-- KKR, a leading global investment firm, and Healthcare Global Enterprises (BSE: 539787; NSE: HCG; “HCG”), a leading healthcare organization in India, today announced the signing of definitive agreements with CVC, a leading global private markets manager, under which funds managed by KKR (“KKR”) will become the largest shareholder in HCG and assume sole control of HCG’s operations. Dr. BS Ajaikumar, Founder of HCG, will take on the role of Non-Executive Chairman and be focused on driving clinical, academic and research and development excellence. This press rele...
Transaction in Own Shares Transaction in Own Shares 21 February, 2025 • • • • • • • • • • • • • • • • Shell plc (the ‘Company’) announces that on 21 February 2025 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: Date of purchase Number of Shares purchased Highest price paid Lowest price paid Volume weighted average price paid per share Venue Currency 21/02/2025 1,441,279 £ 26.7850 £ 26.3450 £ 26.4983 LSE GBP 21/02/2025 41,942 £ 26.7700 £ 26.3700 £ 26.5398 Chi-X (CXE)...
InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process
cyber_Folks is a CEE-leader in hosting, marketing automation and tools for web shops.
Our credit view of this issuer reflects its moderate leverage, offset by its limited revenue raising flexibility because of state imposed levy limits.
A director at Biotage AB bought 41,000 shares at 115.023SEK and the significance rating of the trade was 94/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...
A director at Lucky Strike Entertainment Corp sold 1,747,434 shares at 11.540USD and the significance rating of the trade was 93/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the las...
A director at Tapestry Inc sold 11,917 shares at 88.000USD and the significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
Four Directors at QuantumScape Corp sold/sold after exercising options 196,902 shares at between 5.223USD and 5.231USD. The significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all t...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.